Skip to main content

RA Capital Management — Portfolio, Page 20

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

467
Companies
$56.7B
Total invested
$123.5M
Avg. check
11
Industries
Biotechnology 9Health Care 6Pharmaceutical 4Therapeutics 2Organic Food 2Energy 1+5 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 457–467 of 467
Crescent Pass Energy
January 2019

Crescent Pass Energy is an oil and gas company based in Houston, Texas.

Energy · Houston$75.0M Private Equity
Attune Pharmaceuticals
January 2019

Attune Pharmaceuticals is a private biotechnology company.

Biotechnology · New York$23.0M Series B
Sojournix
January 2019

Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.

Biotechnology · Arlington$44.0M Series C
WhiteSwell
December 2018

WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .

Biotechnology · Ballybrit$30.0M Series B
CiVi Biopharma
May 2018

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.

Biotechnology · Chevy Chase$49.0M Series Unknown
Medeor Therapeutics
January 2018

Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.

Biotechnology · South San Francisco$18.8M Grant
Braeburn
January 2018

We transform the management of OUD to help people begin and sustain recovery.

Health Care · Plymouth Meeting$110.0M Debt Financing
Adeo Health Science
January 2018

Adeo Health Science is consumer health and biotechnology company, focusing on improving immune health in infants

Biotechnology · BostonSeries Unknown
OvaScience
June 2016

OvaScience is a life sciences company focused on the discovery, development and commercialization of treatments for infertility.

Biotechnology · Boston$53.8M Post Ipo Equity
Antera Therapeutics
June 2016

Antera Therapeutics is creating therapies that will prevent allergy development in children.

Biotechnology · Boston$2.0M Seed
Lumena Pharmaceuticals
March 2014

Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.

Biotechnology · San Diego$45.0M Series B

Where RA Capital Management invests

Biotechnology9
Health Care6
Pharmaceutical4
Therapeutics2
Organic Food2
Energy1

About RA Capital Management's portfolio

How many companies has RA Capital Management invested in?▸

RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does RA Capital Management invest in?▸

RA Capital Management's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Organic Food. The firm invests across 11 different industry categories.

What is RA Capital Management's largest investment?▸

Among tracked funding rounds, Braeburn received $110.0M in a Debt Financing round. RA Capital Management's total known invested capital is $56.7B.

What is the average investment size for RA Capital Management?▸

RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.

Reach the founders behind these 467 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →